DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC

Chunli Zhang1, Limin Huang1, Zeyu Li1

  • 1Department of General Surgery, National-Local Joint Engineering Research Center of Biodiagnostic & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, PR China.

Neoplasia (New York, N.Y.)
|July 1, 2025
PubMed

Insights

DHX34 depletion enhances hepatocellular carcinoma (HCC) immunogenicity by activating innate immune responses. This leads to T cell infiltration, impaired tumor growth, and improved survival in mice, suggesting DHX34 as a therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumors evade immune surveillance by reducing immunogenicity.
  • DHX34, an RNA helicase, is crucial for mRNA decay.
  • The role of DHX34 in hepatocellular carcinoma (HCC) immunogenicity is unknown.

Purpose of the Study:

  • To investigate the function of DHX34 in regulating HCC immunogenicity.
  • To explore DHX34's mechanism in controlling tumor immunity.

Main Methods:

  • Analysis of DHX34-deficient HCC tumors in mice.
  • Assessment of T cell infiltration and activation.
  • Investigation of RNA sensing pathways and interferon response.

Main Results:

  • DHX34 depletion led to T cell infiltration and impaired tumor growth in HCC mouse models.
  • DHX34 deficiency caused dsRNA accumulation, activating cytosolic RNA-sensing pathways.
  • This resulted in a type-I interferon response, tumor-intrinsic immunity, and CD8 T cell activation.

Conclusions:

  • DHX34 suppresses dsRNA-driven innate immune activation in HCC, acting as a barrier to immunogenicity.
  • Targeting DHX34 could enhance HCC immunogenicity and synergize with immunotherapy.
  • DHX34 inhibition presents a potential novel therapeutic strategy for HCC.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K